FDA clears CoreLink’s new spinal implant

Spinal implant maker CoreLink has landed FDA 510(k) clearance for a new anterior lumbar (ALIF) interbody device. The Foundation 3D ALIF uses the company’s proprietary mimetic metal technology, which mimics natural bone characteristics, including 100% open-pore architecture and micro-roughened porosity with hydro-wicking properties. The new ALIF design also has patent-pending technology that creates a combination of

CoreLink buys Expanding Orthopedics and its expanding spinal fusion systems

Spinal implant systems maker CoreLink (St. Louis) said today that it has acquired the privately held Israeli medical device company Expanding Orthopedics and its FDA-cleared expanding and articulating FLXfit and FLXfit 15 titanium transforaminal lumbar interbody fusion systems. Financial terms of the deal were not disclosed. Besides acquiring the FLXfit and FLXfit 15, the Expanding Orthopedics

Medtech stories we missed this week: April 20, 2018

From CHF Solutions’ new Italian distribution deal to Masimo’s CE Mark approval, here are five medtech stories we missed this week but thought were still worth mentioning. 1. CHF Solutions signs Italian distribution deal CHF Solutions announced in an April 17 press release that it has signed a new distribution agreement with TRX Italy to distribute

Medtech stories we missed this week: Aug. 25, 2017

From InspireMD’s Swiss distribution deal to CoreLink’s stackable guide wire launch, here are seven medtech stories we missed this week but thought were still worth a mention. 1. InspireMD announces Swiss distribution deal InspireMD announced in an Aug. 25 press release that it has signed an agreement with 1a Medical to distribute the CGuard EPS (Embolic

CoreLink releases the Entasis SI Joint Fusion System

CoreLink, LLC, a designer and manufacturer of spinal implant systems, launched the Entasis Sacroiliac Joint Fusion System to the U.S. markets. Entasis was designed to better address the challenges of sacroiliac (SI) joint fusion procedures through innovation in the delivery of autograft and compression across the joint. Further innovations also provide improvements in ease of